The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis

Histology and Histopathology

Volumn 17, Issue 3, 2002, Pages 961-972

  Afuwape, A O ^a   Kiriakidis, S ^a   Paleolog, Ewa M ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Rheumatoid arthritis; VEGF

Indexed keywords

2 (2,6 DIOXO 3 PIPERIDINYL)PHTHALIMIDINE; ANGIOGENESIS INHIBITOR; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; AUROTHIOMALATE; BUCILLAMINE; CD34 ANTIGEN; CYCLOSPORIN A; CYTOKINE; EMD 69601; FUMAGILLOL CHLOROACETYLCARBAMATE; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; PACLITAXEL; PENICILLAMINE; SALAZOSULFAPYRIDINE; SB 273005; SUPIDIMIDE; THALIDOMIDE; THALIDOMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTHRITIS; ARTICULAR CARTILAGE; BLOOD VESSEL PERMEABILITY; BONE; CLINICAL TRIAL; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; DRUG TOXICITY; EDEMA; HUMAN; JOINT; MOLECULE; NONHUMAN; NUTRITION; OXYGEN CONSUMPTION; PANNUS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SYNOVIUM; VASCULARIZATION;

ANIMALS; ANTIGENS, CD34; ARTHRITIS, RHEUMATOID; ENDOTHELIAL GROWTH FACTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

ANIMALIA;

EID: 0036068479     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (99)

1. NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes
2. NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes
3. Disease-modifying activity of SB 273005, an orally active, nonpeptide alphavbeta3 (vitronection receptor) antagonist, in rat adjuvant-induced arthritis
4. New vessels, new approaches: Angiogenesis as a therapeutic target in musculoskeletal disorders
5. Raised serum vascular edothelial growth factor levels are associated with destructive change in inflammatory arthritis
6. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways
7. The impact of rheumatoid arthritis on employment status in the early years of disease: A UK community-based study
8. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
9. Signaling angiogenesis via p42/p44 MAP kinase and hypoxia
10. Placenta growth factor (PIGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co-expressed with VEGF in synovial fluid
11. Vascular permeability factor/vascular endothelial factor: A multifunctional angiogenic cytokine
12. Angiogenic factor from synovial fluid resembling that from tumours
13. CD40 engagement on synovial fibroblast up-regulates production of vascular endothelial growth factor
14. Thalidomide is an inhibitor of angiogenesis
15. Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum
16. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis
17. Induction of vascular permeability factor (vascular endothelial growth factor) by TGFβ in synovial fibroblasts
18. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
19. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by Ras
20. Anti-TNF alpha therapy of rheumatoid arthritis: What have we learned?
21. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis
22. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitror, is angiogenic in vivo
23. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta - Adrenoreceptor/cAMP/Protein kinase A pathway involving src but independently of Erk1/2
24. The angiogenic pathway "vascular endothelial growth factor/flk-1(KDR)-receptor" in rheumatoid arthritis and osteoarthritis
25. Pathogenesis of rheumatoid arthritis
26. Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low dose methotrexate
27. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis
28. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8
29. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis
30. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium
31. Intra-articular pressure profile of the knee joint in a spectrum of inflammatory arthropathies
32. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells
33. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer
34. Review: angiogenesis: Implications for rheumatoid arthritis
35. The role of angiogenesis in rheumatoid arthritis: Recent developments
36. Hepatocyte growth factor. A cytokine mediating endothelial migration in inflammatory arthritis
37. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis
38. Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint
39. Endothelin-1 induces vascular endothelial growth factor synthesis in osteoblasts: Involvement of p38 mitogen-activated protein kinase
40. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis
41. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
42. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
43. Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis
44. Oxygen tension in synovial fluids
45. Is the beneficial effect of sulphasalazine due to inhibition of synovial neovascularization?
46. The arthritogenic T cell receptor and its ligand in a model of spontaneous arthritis
47. Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine
48. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis
49. Insulin and IGF-I induce VEGF mRNA expression via different signaling pathways
50. p42/p44 MAP kinase module plays a key role in the transcriptional regulation of the vascular endothelial growth factor gene in fibroblasts
51. Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
52. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation
53. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
54. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis
55. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis
56. Vascular endothelial growth factor (VEGF) and its receptors
57. Different regulation of vascular endothelial growth factor expression by the ERK and p38 kinase pathways in v-ras, v-raf, and v-myc transformed cells
58. Combination therapy in rheumatoid arthritis: The animal model perspective
59. Suppression of collagen-induced arthritis using and angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol
60. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: Reduction of vascular endothelial growth factor (VEGF)
61. The effect of thalidomide and 2 analogs on collagen induced arthritis
62. Role of protein kinase Czeta in Ras-mediated transcriptional activation of vascular permeability factor/vascular endothelial growth factor expression
63. Angiogenesis in rheumatoid arthritis: Implications for future therapeutic strategies
64. Angiogenesis in arthritis: Role in disease pathogenesis and as a potential therapeutic target
65. Modulation of angiogenic vascular endothelial growth factor (VEGF) by TNFα and IL-1 in rheumatoid arthritis
66. Angiogenesis inhibition suppresses collagen arthritis
67. A novel angiogenesis inhibitor suppresses rat adjuvant arthritis
68. Hypoxia-stimulated expression of angiogenic growth factors in cervical cancer cells and cervical cancer-derived fibroblasts
69. Premature mortality in patients with rheumatoid arthritis: Evolving concepts
70. Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis
71. Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver
72. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis
73. Ras regulation of vascular endothelial growth factor and angiogenesis
74. Production of platelet derived growth factor B chain (PDGF-B/c-sis) mRNA and immunoreactive PDGF B-like polypeptide by rheumatoid synovium: Coexpression with heparin binding acidic fibroblast growth factor-1
75. Analysis of the histologic variation of synovitis in rheumatoid arthritis
76. Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine
77. Pathogenesis of rheumatoid arthritis: A vascular hypothesis
78. Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in sity in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis
79. Expression of angiogenic factors in juvenile rheumatoid arthritis: Correlation with revascularization of human synovium engrafted into SCID mice
80. Rheumatoid arthritis and osteoarthritis synovial fluid effects on primary human endothelial cell cultures
81. Role of protein kinase C isoforms in phorbol ester-induced vascular endothelial growth factor expression in human glioblastoma cells
82. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
83. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice
84. Collagen arthritis - What can it teach us?
85. Hypoxia and inflammatory synovitis: Observations and speculation
86. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist
87. Lipopolysaccharide augments expression and secretion of vascular endothelial growth factor in rat ventricular myocytes
88. Stretch-induced retinal VEGF expression is mediated by PI3 kinase and PKC-{zeta} but not stretch-induced ERK1/2, Akt, Ras or classical/novel PKC pathways
89. NF-kappaB: A key role in inflammatory diseases
90. Reduced synovial vascularity following TNFα blockade in rheumatoid arthritis
91. Autoimmunity to type II collagen an experimental model of arthritis
92. Effects of sulfhydryl compounds on interleukin-1-induced vascular endothelial growth factor production in human synøvial stromal cells
93. Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells
94. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases
95. Focally regulated endothelial proliferation and cell death in human synovium
96. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase
97. Successful transfer of collagen-induced arthritis to severe combined immunodeficient (SCID) mice
98. Morphometric analysis of synovial membrane blood vessels in rheumatoid arthritis: Associations with the immunohistologic features, synovial fluid cytokine levels and the clinical course
99. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis